|
1 |
Basic Science (Anatomy, physiology, pharmacology, behaviour) |
|
1.1 |
Primary afferents |
|
1.2 |
Spinal cord |
|
1.3 |
Brainstem, thalamus and cortex |
|
1.4 |
Pain pathways |
|
1.5 |
Gene expression |
|
1.6 |
Peripheral sensitization |
|
1.7 |
Central sensitization |
|
1.8 |
Endogenous pain modulation |
|
1.9 |
Signal transduction |
|
1.10 |
Receptors |
|
1.11 |
Ion channels |
|
1.12 |
Addiction |
|
1.13 |
Tolerance |
|
1.14 |
Anticonvulsants |
|
1.15 |
Antidepressants |
|
1.16 |
Biologics/Peptides |
|
1.17 |
Cannabinoids |
|
1.18 |
Local anaesthetics |
|
1.19 |
NSAIDs, COXIBs, Acetaminophen |
|
1.20 |
Opioids |
|
1.21 |
Placebo |
|
1.22 |
Imaging - animals |
|
1.23 |
Imaging - humans |
|
1.24 |
Animal models of acute pain |
|
1.25 |
Human models of acute pain |
|
1.26 |
Animal models of chronic pain |
|
1.27 |
Human models of chronic pain |
|
1.28 |
Itch |
|
2 |
Pain states |
|
2.1 |
Joint and muscle pain |
|
2.2 |
Arthritis |
|
2.3 |
Neck and back pain |
|
2.4 |
Fibromyalgia |
|
2.5 |
Complex regional pain syndrome |
|
2.6 |
Migraine headaches |
|
2.7 |
Other headaches |
|
2.8 |
Orofacial pain |
|
2.9 |
Neuropathic pain |
|
2.10 |
Amputation pain |
|
2.11 |
Visceral Pain |
|
2.12 |
Pain and dementia |
|
2.13 |
Pain in Children |
|
2.14 |
Pain in the Elderly |
|
2.15 |
Gender differences |
|
2.16 |
Perioperative Pain |
|
2.17 |
Procedural Pain |
|
3 |
Affective, cognitive, social and behavioral processes |
|
3.1 |
Affective modulation |
|
3.2 |
Executive control |
|
3.3 |
Cognitive processes/biases |
|
3.4 |
Learning processes |
|
3.5 |
Expectancies |
|
3.6 |
Goal pursuit |
|
3.7 |
Pain and identity |
|
3.8 |
Resilience |
|
3.9 |
Social and occupational context factors |
|
3.10 |
Empathy |
|
3.11 |
Patient-health care provider communication |
|
3.12 |
Pain behaviour |
|
4 |
Pain treatment (conservative) |
|
4.1 |
Acute pain / perioperative pain – Opioids |
|
4.2 |
Acute pain / perioperative pain – Other |
|
4.3 |
Cancer pain – Opioids |
|
4.4 |
Cancer pain – Other |
|
4.5 |
Neuropathic pain |
|
4.6 |
Visceral pain |
|
4.7 |
Palliative Care |
|
4.8 |
Anticonvulsants |
|
4.9 |
Antidepressants |
|
4.10 |
Cannabinoids |
|
4.11 |
NSAIDs, COX2 inhibitors and acetaminophen |
|
4.12 |
Opioids |
|
4.13 |
Novel therapeutic agents |
|
4.14 |
Topical analgesics |
|
4.15 |
Placebo |
|
4.16 |
Preemptive analgesia |
|
4.17 |
Complementary and alternative medicine |
|
4.18 |
Physiotherapy |
|
4.19 |
Rehabilitation |
|
5 |
Pain treatment (invasive) |
|
5.1 |
Brain, spinal and peripheral neural stimulation |
|
5.2 |
Nerve blocks, indwelling catheters |
|
5.3 |
Radiofrequency blocks |
|
5.4 |
Spinal analgesia |
|
5.5 |
Sympathetic blocks |
|
6 |
Pain treatment (psychological) |
|
6.1 |
Cognitive-behavioral treatment |
|
6.2 |
Biofeedback |
|
6.3 |
Relaxation |
|
6.4 |
Hypnosis |
|
6.5 |
Extinction |
|
6.6 |
Exposure-based treatments |
|
6.7 |
Mindfulness |
|
6.8 |
Partner assisted treatment |
|
6.9 |
Family based treatment |
|
6.10 |
Internet based treatments |
|
6.11 |
Educational approaches |
|
7 |
Multidisciplinary pain treatments |
|
8 |
Epidemiology, assessment, organisation of pain treatment |
|
8.1 |
Epidemiology of Pain |
|
8.2 |
Assessment |
|
8.3 |
Clinical outcomes measurement |
|
8.4 |
Documentation |
|
8.5 |
Systematic Reviews |
|
8.6 |
Acute pain services |
|
9 |
Ethics, education, history, law |
|
9.1 |
Ethics – animal research |
|
9.2 |
Ethics - clinical practice |
|
9.3 |
Education / Professional |
|
9.4 |
Education / Lay |
|
9.5 |
Public relations |
|
9.6 |
History of pain |
|
9.7 |
Legal issues related to pain and pain treatment |